04:22 PM EST, 11/11/2025 (MT Newswires) -- Centessa Pharmaceuticals ( CNTA ) is planning an underwritten public offering of American depositary shares, each representing one ordinary share.

Underwriters have a 30-day option to purchase up to an additional 15% of the ADSs with all securities in the offering to be sold by the company.

The price range, timing and terms of the offering remain subject to market conditions, Centessa said Tuesday in a statement.

The company's shares fell 2.4% in after-hours trading.